Business, energy, technology, markets and global industry news from Business News Today

Spruce Biosciences

PharmaDeviceNews Spruce Biosciences
Representative image: A pediatric neurology research setting highlights the clinical focus on tralesinidase alfa, enzyme replacement therapy, and long-term treatment advances for Sanfilippo syndrome type B.
Pharma & Biotech

Could Spruce Biosciences finally change the Sanfilippo syndrome type B treatment landscape?

Spruce Biosciences’ MPS IIIB data raise a pivotal question: can tralesinidase alfa turn biomarker gains into disease-changing therapy?

Read More
Pharma & Biotech

Harbour BioMed converts SPR202 partnership into strategic stake in Spruce Biosciences

Harbour BioMed acquires stake in Spruce Biosciences, reinforcing its SPR202 collaboration. Find out what this signals for CRH-targeted therapies.

Read More